Currently, three more mutations (p.Y36C, p.Q376R, p.Q358S) in the POT1 gene have been identified from CLL patients, predicted to disrupt the interaction of POT1 with TPP1 and telomere overhang which consequently contributed to the CLL pathogenesis [44]. The gene discussed is TPP1; the disease is B-cell chronic lymphocytic leukemia.